FRAS1 Antikörper (PE)
Kurzübersicht für FRAS1 Antikörper (PE) (ABIN1712692)
Target
Alle FRAS1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human FRAS1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- FCM(1:20-100)
-
Kommentare
-
Exitation/Emission: 480,565nm/578nm
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at 4°C
-
Haltbarkeit
- 12 months
-
-
- FRAS1 (Fraser Syndrome 1 (FRAS1))
-
Andere Bezeichnung
- Fras1
-
Hintergrund
-
This gene encodes an extracellular matrix protein that appears to function in the regulation of epidermal-basement membrane adhesion and organogenesis during development. Mutations in this gene cause Fraser syndrome, a multisystem malformation that can include craniofacial, urogenital and respiratory system abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009].
Subcellular location: Extracellular
Synonyms: Extracellular matrix protein FRAS1, Fras 1, Fras1, FRAS1_HUMAN, Fraser syndrome 1.
Target
-